share_log

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

S-8：员工福利计划证券登记
美股sec公告 ·  04/26 16:43
Moomoo AI 已提取核心信息
Cardio Diagnostics Holdings, Inc., a Delaware-based company, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on April 26, 2024. The purpose of the filing is to register an additional 1,060,458 shares of common stock for the Cardio Diagnostics Holdings, Inc. 2022 Equity Incentive Plan. This move follows the previous registration of 3,265,516 shares under the same plan on March 22, 2023. The newly registered shares are of the same class as those previously registered. The company's Annual Report for the fiscal year ended December 31, 2023, is incorporated by reference into this Registration Statement. Cardio Diagnostics Holdings has also undertaken to file post-effective amendments during the offering period to reflect any material changes.
Cardio Diagnostics Holdings, Inc., a Delaware-based company, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on April 26, 2024. The purpose of the filing is to register an additional 1,060,458 shares of common stock for the Cardio Diagnostics Holdings, Inc. 2022 Equity Incentive Plan. This move follows the previous registration of 3,265,516 shares under the same plan on March 22, 2023. The newly registered shares are of the same class as those previously registered. The company's Annual Report for the fiscal year ended December 31, 2023, is incorporated by reference into this Registration Statement. Cardio Diagnostics Holdings has also undertaken to file post-effective amendments during the offering period to reflect any material changes.
总部位于特拉华州的Cardio Diagnostics Holdings, Inc. 于2024年4月26日向美国证券交易委员会（SEC）提交了S-8表格的注册声明。该文件的目的是为Cardio Diagnostics Holdings, Inc.2022年股权激励计划再注册1,060,458股普通股。此举是在2023年3月22日根据同一计划注册3,265,516股股票之后采取的。新注册的股票与先前注册的股票属于同一类别。公司截至2023年12月31日的财政年度的年度报告以引用方式纳入本注册声明。Cardio Diagnostics Holdings还承诺在发行期内提交生效后的修正案，以反映任何重大变化。
总部位于特拉华州的Cardio Diagnostics Holdings, Inc. 于2024年4月26日向美国证券交易委员会（SEC）提交了S-8表格的注册声明。该文件的目的是为Cardio Diagnostics Holdings, Inc.2022年股权激励计划再注册1,060,458股普通股。此举是在2023年3月22日根据同一计划注册3,265,516股股票之后采取的。新注册的股票与先前注册的股票属于同一类别。公司截至2023年12月31日的财政年度的年度报告以引用方式纳入本注册声明。Cardio Diagnostics Holdings还承诺在发行期内提交生效后的修正案，以反映任何重大变化。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息